Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary Gilliland

Showing results (91-100 of 182) with videos related to

Pageof 19
Sort By:
Blood|February 29, 2008
Structural and numerical variation of FLT3/ITD in pediatric AMLSoheil Meshinchi, Derek L Stirewalt, Todd A Alonzo, et al.
Blood|May 6, 2006
Oncogenic K-ras cooperates with PML-RAR alpha to induce an acute promyelocytic leukemia-like diseaseIris T Chan, Jeffery L Kutok, Ifor R Williams, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 21, 2017
Unifying mechanism for different fibrotic diseasesGerlinde Wernig, Shih-Yu Chen, Lu Cui, et al.
American Journal of Human Genetics|June 15, 2007
Highly sensitive method for genomewide detection of allelic composition in nonpaired, primary tumor specimens by use of affymetrix single-nucleotide-polymorphism genotyping microarraysGo Yamamoto, Yasuhito Nannya, Motohiro Kato, et al.
The Journal of Clinical Investigation|February 18, 2004
Conditional expression of oncogenic K-ras from its endogenous promoter induces a myeloproliferative diseaseIris T Chan, Jeffery L Kutok, Ifor R Williams, et al.
Blood|March 4, 2010
The Apc(min) mouse has altered hematopoietic stem cell function and provides a model for MPD/MDSSteven W Lane, Stephen M Sykes, Fatima Al-Shahrour, et al.
Stem Cells (Dayton, Ohio)|May 28, 2010
Hematopoietic stem cell defects in mice with deficiency of Fancd2 or Usp1Kalindi Parmar, Jungmin Kim, Stephen M Sykes, et al.
Blood|February 24, 2006
Prospective analysis of TEL/AML1-positive patients treated on Dana-Farber Cancer Institute Consortium Protocol 95-01Mignon L Loh, Meredith A Goldwasser, Lewis B Silverman, et al.
Cancer Cell|April 5, 2003
MOZ-TIF2-induced acute myeloid leukemia requires the MOZ nucleosome binding motif and TIF2-mediated recruitment of CBPKenji Deguchi, Paul M Ayton, Melina Carapeti, et al.
Cancer Cell|December 21, 2004
MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitorsBrian J P Huntly, Hirokazu Shigematsu, Kenji Deguchi, et al.
Pageof 19

Showing results (91-100 of 182) with videos related to

Sort By:
Pageof 19
Blood|February 29, 2008
Structural and numerical variation of FLT3/ITD in pediatric AMLSoheil Meshinchi, Derek L Stirewalt, Todd A Alonzo, et al.
Blood|May 6, 2006
Oncogenic K-ras cooperates with PML-RAR alpha to induce an acute promyelocytic leukemia-like diseaseIris T Chan, Jeffery L Kutok, Ifor R Williams, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 21, 2017
Unifying mechanism for different fibrotic diseasesGerlinde Wernig, Shih-Yu Chen, Lu Cui, et al.
American Journal of Human Genetics|June 15, 2007
Highly sensitive method for genomewide detection of allelic composition in nonpaired, primary tumor specimens by use of affymetrix single-nucleotide-polymorphism genotyping microarraysGo Yamamoto, Yasuhito Nannya, Motohiro Kato, et al.
The Journal of Clinical Investigation|February 18, 2004
Conditional expression of oncogenic K-ras from its endogenous promoter induces a myeloproliferative diseaseIris T Chan, Jeffery L Kutok, Ifor R Williams, et al.
Blood|March 4, 2010
The Apc(min) mouse has altered hematopoietic stem cell function and provides a model for MPD/MDSSteven W Lane, Stephen M Sykes, Fatima Al-Shahrour, et al.
Stem Cells (Dayton, Ohio)|May 28, 2010
Hematopoietic stem cell defects in mice with deficiency of Fancd2 or Usp1Kalindi Parmar, Jungmin Kim, Stephen M Sykes, et al.
Blood|February 24, 2006
Prospective analysis of TEL/AML1-positive patients treated on Dana-Farber Cancer Institute Consortium Protocol 95-01Mignon L Loh, Meredith A Goldwasser, Lewis B Silverman, et al.
Cancer Cell|April 5, 2003
MOZ-TIF2-induced acute myeloid leukemia requires the MOZ nucleosome binding motif and TIF2-mediated recruitment of CBPKenji Deguchi, Paul M Ayton, Melina Carapeti, et al.
Cancer Cell|December 21, 2004
MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitorsBrian J P Huntly, Hirokazu Shigematsu, Kenji Deguchi, et al.
Pageof 19